You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
For your morning dose of disappointment, here's a sobering look at the pharma industry from the Wall Street Journal.
SNPs and other genetic variation are linked to differing response to antipsychotic drugs in patients with mental illness.
Nature looks in on creative commons licenses for genome papers, German funding increases, type one diabetes, and more.
A supercomputer is good to the environment.
An underfunded FDA puts consumers at risk, a report says.
Open science gains ground through Google Code.
Salon's take on Venter and the rise of the intellectual entrepreneur.
Tech Review covers a new database of organ-specific gene expression patterns linked to aging.
EMBL has a new phylogenetics visualization toy out on the Internet.
A blogger writes about research on sexually antagonistic genes.
A report says that toxins in the water are spurring genetic mutations among Indian people living in the Punjab.
From Wired, articles on California's stem cell agency and new findings from one of the teams that turned a skin cell into what looks like an embryonic stem cell.
Genetic advisors to the British government say genetic testing is "a dangerous waste of money."
Genomeboy attempts to clear up confusion about costs for sequencing genomes and exomes.
The Boston Globe has an article about the war on cancer, saying that despite some progress, there's growing discouragement about emerging victorious.
Novartis and MorphoSys expand a collaboration in a deal valued at $600 million.
At long last, George Church's Personal Genome Project gets a new website. Check out info on the next chance to participate -- enrollment opens in early 2008.
Science focuses on the nucleus but also has horizontal gene transfer and the FTO gene.
The Economist has an article about how innate immunity seems to stem from genomic variation.
Genome sequencing company Knome is open for business.
David Hamilton discusses Intelligent Bio-Systems in his latest post.
A blogger writes about making bioinformatics software portable.
In Nature this week, there's stem cells, scientific ethics, p53, the nuclear pore complex, and more.
Bora Zivkovic wonders if the term "gene" is outdated.
The New Yorker offers a feature on scientists who bring back extinct viruses with new genomic technology.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.